42 results on '"Rašlová, K."'
Search Results
2. Relationship between plasma fenofibric acid levels and the effect of micronized fenofibrate on cholesterol, low-density-lipoprotein cholesterol and apolipoprotein B in patients with primary hypercholesterolemia
3. Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes
4. Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk
5. Nutritional supplementation with antioxidants decreases chromosomal damage in humans
6. Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage
7. Are risk-based LDL-c goals achieved in primary and secondary care in central and Eastern Europe? comparison with other Europe regions from the DA VINCI observational study
8. The Molecular Genetic Background of Familial Hypercholesterolemia: Data From the Slovak Nation-Wide Survey.
9. Molecular analysis of genes involved in lipoprotein lipase deficiency in Slovak patients with familial chylomicronemia
10. Association of Metabolic and Genetic Factors With Cholesterol Esterification Rate in HDL Plasma and Atherogenic Index of Plasma in a 40 Years Old Slovak Population
11. Corrigendum to “Insulin detemir and insulin aspart: A promising basal-bolus regimen for type 2 diabetes” [Diabetes Research and Clinical Practice 66 (2004) 193–201]
12. Antioxidant supplementation reduces inter-individual variation in markers of oxidative damage
13. HT03-IS-003 Diagnosis and treatment of familial hypercholesterolemia in Central-Eastern European Countries
14. W02-P-011 Markers of oxidative damage to lipids and DNA related to seasonal variations in diet
15. T01-P-021 Dyslipidemia, metabolic syndrome and global risk assessment in quadragenarian Slovak population
16. Effect of C677T methylenetetrahydrofolate reductase gene polymorphism on plasma homocysteine levels in ethnic groups.
17. DNA damage and antioxidants; fluctuations through the year in a central European population group
18. Risk factors for atherosclerosis in survivors of myocardial infarction and their spouses: Comparison with spousal pairs without personal and family history of atherosclerosis
19. RELATIONSHIP BETWEEN PLASMA FENOFIBRIC ACID LEVELS AND THE EFFECT OF MICRONIZED FENOFIBRATE ON CHOLESTEROL, LOW DENSITY LIPOPROTEIN CHOLESTEROL AND APOLIPOPROTEIN B IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA.
20. Effect of 677C → T mutation of 5,10-methylenetetrahydrofolate reductase gene and nutrition on plasma homocystein levels in slovak adolescent population
21. Increased level of oxidative stress to the DNA in lymphocytes of patients with Morbus Bechterew
22. 2.P.246 Methylentetrahydrofolate reductase genotypes in young survivors of myocardial infarction
23. Relationship of risk factors in families with genetic predisposition to atherosclerosis
24. Insulin Detemir: A Review of its Use in the Management of Diabetes Mellitus.
25. Abstract: P1371 DIFFERENCES IN RISK FACTORS ACCORDING TO FAMILY HISTORY OF CARDIOVASCULAR DISEASE IN 40 YEARS OLD SLOVAK POPULATION
26. CARDIOVASCULAR RISK ASSESSMENT BY ATHEROGENIC INDEX OF PLASMA [LOG(TG/HDL-C)]
27. We-P14:452 Effect of antioxidant supplementation on genetic stability and lipid peroxidation in middle-aged men
28. W09.252 Familial defective APOB-100 in Slovak patients with primary hypercholesterolemia
29. ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design
30. Familial hypercholesterolaemia [8] (multiple letters)
31. ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic Epidemiology
32. Plasma antioxidant status and LDL oxidizability in healthy men after dietary supplementation with mixture of antioxidant nutrients
33. 1P-0106 Effect of apoE gene polymorphism on plasma lipid levels and markers of metabolic syndrome in ethnic groups
34. HT03-IS-003 Diagnosis and treatment of familialhypercholesterolemia in Central-Eastern European Countries
35. W02-P-011 Markers of oxidative damage to lipidsand DNA related to seasonal variations in diet
36. Evolocumab is Initiated in Central and Eastern Europe at Much Higher LDL-C Levels Than Recommended in Guidelines: Results from the Observational HEYMANS Study.
37. Lipid-lowering therapy use in primary and secondary care in Central and Eastern Europe: DA VINCI observational study.
38. Treatment pattern of familial hypercholesterolemia in Slovakia: Targets, treatment and obstacles in common practice.
39. ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design.
40. ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic Epidemiology.
41. [Diabetes and dyslipidemia: Why are they so closely related?]
42. Genetic determinants of quantitative traits associated with cardiovascular disease risk.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.